Text/Yangcheng Evening News All Media Reporter Chen Hui Correspondent Peng Fuxiang Liang Jiayun
Photo/Provided by the hospital (except for the signature)
More than 10% of the population in my country suffers from chronic kidney disease , The development of chronic kidney disease to the end stage is uremia. In addition to kidney transplantation, the conventional treatment methods for patients with uremia are peritoneal dialysis and hemodialysis. The number of patients who maintain their lives through peritoneal dialysis in my country exceeds 100,000.
The reporter learned from the First Affiliated Hospital of Sun Yat-sen University that after the new generation of dialysate was approved for marketing in my country, it has been used in the hospital, and an electronic prescription for in-hospital medicine has been issued. , The first medical institution in the mainland that can apply new dialysate in the hospital.
Uraemia routine treatment is peritoneal dialysis and hemodialysis/Vision China
Peritoneal dialysis There is no need for frequent trips to the hospital
Peritoneal dialysis is referred to as peritoneal dialysis, which uses the peritoneum as a dialysis membrane to filter the blood in the abdominal cavity through the dialysate to remove toxins, metabolic wastes and excess from the body. moisture.
Professor Yang Xiao from the Department of Nephrology, Zhongshan First Hospital, said that compared with hemodialysis, peritoneal dialysis is a home-based treatment that does not require frequent trips to the hospital. This advantage is particularly prominent during the epidemic.
Professor Yang Xiao issued the first new dialysate prescription
The traditional dialysate for peritoneal dialysis is based on Glucose is the main component. However, for patients on peritoneal dialysis with fluid overload, ultrafiltration is required with high-concentration glucose dialysate. Glucose can be absorbed through the peritoneum during the peritoneal retention of the dialysate, resulting in a decrease in the osmotic efficiency of the dialysate. Especially during the long-term abdominal retention treatment, the ultrafiltration volume is reduced and even fluid is absorbed into the body; in addition, glucose can be absorbed by the peritoneum, causing blood sugar levels. Fluctuations can also cause metabolic disorders such as elevated blood lipids and peritoneal damage, increasing the risk of cardiovascular disease.
The new type of dialysate is especially suitable for these people
It is understood that the new type of dialysate contains dextran, which is not easily absorbed by the peritoneum due to its large molecular weight. It does not contain glucose, greatly improves dialysis efficiency, and can achieve continuous ultrafiltration for up to 16 hours, thus improving dialysis efficiency, significantly improving patient volume overload, toxin removal and glucose and lipid metabolism, and reducing the risk of cardiovascular disease and death. This dialysate has been widely used in more than 80 countries around the world since it was launched in Europe in 1997.
As of now, Professor Yang Xiao has prescribed a new type of peritoneal dialysis fluid for many patients. Feedback from patients after use shows that the ultrafiltration effect of peritoneal dialysis is remarkable, the single bag of long abdominal discharge exceeds 200-700ml, and the edema and blood pressure are quickly improved. However, the disadvantage of the new type of dialysate is that the price is high. The cost of a bag is 198 yuan, and patients who need it usually need to use a bag every day. At present, doctors will give priority to patients with special needs, such as patients with rapid peritoneal transport, diabetic peritoneal dialysis patients, patients with peritonitis, and patients with ultrafiltration failure who have severe fluid overload or lead to heart failure.
Lin Jianxiong explained the connection method of the new peritoneal dialysis fluid
Lin Jianxiong, head nurse of the Department of Nephrology, introduced that she Just taught a peritoneal dialysis patient with peritonitis how to use a new dialysis solution. This patient also had diabetes himself and developed peritonitis associated with peritoneal dialysis. Volume overload is common in peritonitis. In the past, it may take a period of time to switch to hemodialysis when the application of high-concentration dialysate is ineffective, and now the use of new dialysate does not require such tossing.